Digest Network Come funziona
Network
/
Società
En
Non verificato

Encoded Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

14 comunicati stampa

Guarda tutti i comunicati
09/09/2026
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
02/09/2026
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Encoded Therapeutics to Present New Data on ETX101 Gene Therapy for Dravet Syndrome at the 16th European Epilepsy Congress
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
12/05/2026
Eventi
Fiere
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Encoded Therapeutics Presents New Preclinical Data at ASGCT 2026 Highlighting Precision Vector Engineering Across Neurology Programs
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
08/01/2026
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Eventi
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
05/01/2026
Eventi
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
16/12/2025
Mercato del lavoro
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Encoded Therapeutics Strengthens Clinical Leadership Team with Appointment of Professor Joseph Sullivan, M.D., as Vice President of Clinical Development
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
05/12/2025
Scienza
Farmaceutica
Vetrine/Shopping
Biotecnologia
Infanzia
Medicina - Varie
Assistenza all'Infanzia
Igiene alimentare
Salute
Eventi
Industria
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
01/12/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Eventi
Industria
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Scienza
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
Industria
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0
02/09/2025
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Industria
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
Fonte
Encoded Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0